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The current concept of epigenetic repression is based on one repressor unit corresponding to one silent gene. This notion,
however, cannot adequately explain concurrent silencing of multiple loci observed in large chromosome regions. The
long-range epigenetic silencing (LRES) can be a frequent occurrence throughout the human genome. To comprehensively
characterize the influence of estrogen signaling on LRES, we analyzed transcriptome, methylome, and estrogen receptor
alpha (ESR1)-binding datasets from normal breast epithelia and breast cancer cells. This ‘‘omics’’ approach uncovered 11
large repressive zones (range, 0.35;5.98 megabases), including a 14-gene cluster located on 16p11.2. In normal cells, estrogen
signaling induced transient formation of multiple DNA loops in the 16p11.2 region by bringing 14 distant loci to focal ESR1-
docking sites for coordinate repression. However, the plasticity of this free DNA movement was reduced in breast cancer
cells. Together with the acquisition of DNA methylation and repressive chromatin modifications at the 16p11.2 loci, an
inflexible DNA scaffold may be a novel determinant used by breast cancer cells to reinforce estrogen-mediated repression.
[Supplemental material is available online at http://www.genome.org. The sequencing and microarray data from this
study have been submitted to the NCBI Gene Expression Omnibus (http://www.ncbi.nlm.nih.gov/geo) under accession
no. GSE21068.]
Epigenetic control of gene silencing plays a causal role in the de-
velopment of human cancers. This form of transcriptional re-
pression is commonly associated with loss of tumor-suppressor
functions, DNA mismatch repair, cell cycle regulation, and drug
resistance (Costello et al. 2000; Feinberg et al. 2006; Roberti et al.
2006; Jones and Baylin 2007). De novo DNA methylation is a fre-
quent epigenetic hallmark observed in promoter CpG islands of
repressed genes (Clark 2007; Jones and Baylin 2007). Unlike genetic
mutations, this epigenetic change does not alter the DNA sequence
itself, but can stably transmit the heritable information from pro-
genitor cells to the progeny (Feinberg et al. 2006; Ho et al. 2006;
Newbold et al. 2006). In addition, the silencing state is initiated and
coordinately maintained by histone modifications (Clark 2007;
Jones and Baylin 2007). For example, polycomb-modified tri-
methylation of histone H3 on lysine 27 (H3K27me3) may result in
a closed chromatin configuration, rendering a promoter CpG island
inaccessible to RNA polymerase II (Pol II) transcription complexes
(Jones and Baylin 2007; Hansen et al. 2008). The process of acquired
DNA methylation then occurs slowly. Increased methylation den-
sity in the CpG islandmaymark the entry of a gene into permanent
silencing (Leu et al. 2004; Robertson 2005; Jones and Baylin 2007).
Using candidate gene approaches, molecular mechanisms
underlying epigenetic gene silencing were generally thought to
occur at the local chromatin level primarily in promoter regions of
individual loci. However, recent genome-wide surveys uncovered
contiguous loci frequently hypermethylated in cancer cells, sug-
gesting that epigenetic repression can have a ‘‘geographic in-
fluence’’ on neighboring genes (Frigola et al. 2006; Novak et al.
2006; Clark 2007). Specifically, Frigola et al. (2006) found hyper-
methylation of 12 nearby CpG islands located within a ;4 Mb
cluster on chromosome 2q14.2 in colorectal cancer. Interestingly,
neighboring genes spanning the region were also epigenetically
suppressed, even though the involved CpG islands remain un-
methylated. Moreover, despite the lack of promoter CpG island
hypermethylation, the suppression of these genes could similarly
be relieved by demethylating drug treatment (Frigola et al. 2006).
Concurrent hypermethylation of adjacent CpG islands was also
observed in smaller (<100 kb) regions of contiguous genes, in-
cluding theHOXA@ on 7p15.2 in breast cancer (Novak et al. 2006),
the TNFRSF10 cluster on 8p21 in neuroblastoma (van Noesel et al.
2003), the HLA class I genes on 6p21.2 in esophageal cancer (Nie
et al. 2001), and the TCF21-related loci on 6q23-24 in lung and
head and neck cancers (Smith et al. 2006). Taken together, these
studies indicate that long-range epigenetic silencing (LRES) (Clark
2007) may be a more common phenomenon in cancer than pre-
viously recognized. However, the mechanism responsible for
concurrent distal regulation is currently unclear.
Previously, our laboratory developed an in vitro model for
initiating epigenetic alterations in breast progenitor cells (Cheng
et al. 2008; Hsu et al. 2009). In thismodel, pre-exposure to estrogen
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and related endocrine disruptors during mammosphere stage
permanently alters estrogen receptor alpha (ESR1)-mediated tran-
scription programs in progenitors and subsequently triggers epi-
genetic repression of target genes later observed in the differenti-
ated progeny (Cheng et al. 2008; Hsu et al. 2009). This epigenetic
process likely disrupts tumor-suppressor functions and promotes
neoplastic transformation of ESR1-positive epithelial cells (Cheng
et al. 2008; Rodriguez et al. 2008; Hsu et al. 2009).
The objective of the current study was to determine whether
LRES can occur in large chromosomal regions of the breast epi-
thelial genome. We extended the study of our progenitor model,
coupled with global analysis of gene transcription, DNA methyl-
ation, and ESR1 binding data. Our integrative analysis identified
11 large conserved chromosomal regions concurrently repressed
by estrogen signaling. Functional analysis of normal breast epi-
thelial cells showed that activation of estrogen signaling induces
transient formation of DNA loops in a 16p11.2 gene cluster by
bringing 14 distant promoters to two ESR1 binding sites for co-
ordinate repression. This transient movement is lost in cancer
cells, and the establishment of permanent loop structure is present
in the epigenetically repressed region. The specific DNA loop
structure described in this study may be a novel epigenetic mark
used to reinforce LRES in cancer cells.
Results
Identification of large chromosomal regions subject
to estrogen-mediated epigenetic repression
Breast progenitors were propagated as spherical mammospheres in
suspension culture (Dontu et al. 2003) and pre-exposed to 17b-
estradiol (E2, 70 nM) or vehicle for 3wk (Fig. 1A).When transferred
to collagen substratum, these progenitors attached to the floor of
culture dishes and subsequently differentiated into epithelial cells,
also called mammosphere-derived epithelial cells (MDECs) (Hsu
et al. 2009). To determine heritable influence of this estrogenic
exposure on gene repression, step-wise integration of global
mapping data obtained from MDECs and breast cancer cells was
conducted (Fig. 1B). First, differential profiles of Pol II bindingwere
determined in E2-pre-exposed MDECs relative to control cells
by chromatin immunoprecipitation coupled with massively
parallel sequencing (ChIP-seq) (Fig. 1C; Table 1). Enriched (n =
1106) and depleted (n = 683) Pol II binding sites were identified in
E2-pre-exposed MDECs (Fig. 1D). Second, to identify genomic re-
gions that were subject to estrogen-mediated repression during
neoplastic development, we compared profiles of depleted PoI II
binding in MDECs with those of the ESR1-positive MCF-7 breast
cancer cells stimulatedwith E2 for 4 h (Fig. 1E). The aimof this initial
analysis was to identify chromosomal regions in E2-stimulated
MCF-7 cells devoidof PoI II binding (for example, see Fig. 3A, below).
Third, to confirm whether this repression is attributed to an epige-
neticmechanism,we integrated the aforementioned PoI II data with
global DNA methylation profiles of MCF-7 cells derived from
a MeDIP-chip (methylated DNA immunoprecipitation microarray)
experiment. Last, we examined the presence of ESR1 binding sites in
these DNA methylation-enriched regions using a published ChIP-
chip data set ofMCF-7 cells (Carroll et al. 2005, 2006).With this step-
wise integrated approach, 11 large chromosomal zones (0.35–5.98
Mb) were identified, including a total of 108 candidate genes that
might undergo estrogen-mediated epigenetic repression in breast
cancer cells (Fig. 2; Supplemental Fig. S1; Supplemental Table S1). In
silico analysis of published expression data from48 breast cancer cell
lines (Neve et al. 2006) confirmed our initial finding that genes lo-
calized in these large chromosomal regions are preferentially down-
regulated in ESR1-positive cancer cell lines (Fig. 3B; Supplemental
Fig. S1A–J).
Concurrent silencing of a 14-gene cluster on chromosome
16p11.2 is mediated through an ESR1-dependent pathway
To experimentally validate the aforementioned global findings, we
focused on a cluster (;0.4 Mb) of 14 repressed genes located on
16p11.2 (Fig. 3A). These genes are known to encode diverse cellular
functions associatedwith stress response,mitogen-activated protein
kinases, ion transport, and chromatin remodeling (Supplemental
Table S2). RT-qPCR analysis of the gene cluster was conducted in
unexposed MDECs transiently stimulated with E2 or a synthetic
estrogen, diethylstilbestrol (DES, 70 nM). Progressive repression
(1.2- to 2.0-fold decrease) of these genes was observed over a 24-h
period (Fig. 4A; Supplemental Fig. S2). The expression levels of these
14 genes appeared to be down-regulated by 1.9- to 6.8-fold in
unstimulated MCF-7 cells compared with unstimulated MDECs
(Supplemental Figs. S2, S3). However, greater repressive effects (1.3-
to 3.9-fold decrease) were observed when MCF-7 cells were further
stimulated with E2 (Fig. 4B, lanes 1,5; Supplemental Fig. S3). To
investigatewhether this repression could be attributed to epigenetic
mechanisms, MCF-7 cells were treated with a demethylating agent,
5-aza-29-deoxycytidine (DAC, 1 mM), and/or a histone deacetylase
inhibitor, trichostatin A (TSA, 1 mM). Treatment with either epige-
netic drug resulted in partial gene reactivation, while synergistic re-
expression of the 14 genes was observed following combined DAC
plus TSA (Fig. 4B, lanes 1–4). Subsequent E2 treatment led to resi-
lencing of these genes (lanes 5–8), suggesting a significant role of
estrogen signaling inmediating this epigenetic repression. Although
treatment ofMCF-7 cells with an ESR1 antagonist, ICI182780, alone
partially abrogated repression of these 14 genes, this derepression
was more profound after further epigenetic drug treatment (i.e.,
DAC and/or TSA) (lanes 9–12). Since E2 treatment was not included
in these treatments, we could not overlook the possibility that
a nonestrogen-stimulated ESR1-dependent pathway, e.g., mitogen-
activated kinase signaling transduction (Jensen and Jordan 2003),
was responsible for repression of the 14 genes. Therefore, to further
prove that this epigenetic repression was mediated through an es-
trogen-stimulated ESR1-dependent pathway, we treatedMCF-7 cells
with the combination of ICI182780 and E2 (lane 13). Gene reac-
tivation by the combined treatment was greater than ICI182780
alone (lane 9). In the presence of epigenetic drugs, increased reac-
tivation of the 14 genes was further observed (lanes 14–16).
While the results of these pharmacological experiments un-
derscore that control of gene silencing in breast cancer is highly
complex, our observations suggest that (1) estrogen signaling ini-
tiates the repression of the 16p11.2 loci in breast epithelial cells; (2)
this repression is partly mediated through an ESR1-dependent
pathway; and (3) persistent repression of the 16p11.2 loci in cancer
cells may be further maintained by DNAmethylation and histone
modifications.
Concurrent silencing of the 16p11.2 gene cluster is initiated
in estrogen-exposed progenitor cells and recapitulated
in an animal exposure model
To determine whether long-term environmental exposure to
estrogen-like chemicals can initiate this epigenetic repression
(Fenton 2006; Ho et al. 2006; Schaffer et al. 2006; Dolinoy et al.
734 Genome Research
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2007), progenitor-containingmammospheres were exposed to E2,
DES, daidzein, 1,3,5-tris(4-hydroxyphenyl)-4-propyl-1H-pyrazole
(PPT), 4-nonylphenol (NP), N-butyl-benzyl phthalate (BBP),
di(2-ethylhexyl)-phthalate (DEHP), 4,49-dichloro-biphnyl (PCB),
and bisphenol A (BPA) for 3 wk (see the treatment dosages in
Fig. 4 legend). Without further exposure, these progenitors were
differentiated into epithelial cells (MDECs) in two-dimensional
collagen stratum for 2;3 wk. Expression profiles of the 16p11.2
cluster in the pre-exposedMDECswere then analyzed by RT-qPCR.
Concurrent repression of these geneswas confirmed (1.4- to 3.4-fold
decrease) in E2-pre-exposed MDECs relative to the control (Fig. 4C;
Supplemental Fig. S4). Suppressive effects varied for the different
environmental exposures, indicating differential sensitivity of pro-
genitors to these estrogenic ligands.
Since this 16p11.2 cluster is highly conserved in mammalian
species (see the list of the sequence homology betweenhuman and
Figure 1. Integrative mapping of large genomic zones subject to estrogen-mediated epigenetic repression. (A) Experimental scheme. Progenitor cells,
propagated into floating mammospheres, were exposed to different estrogenic compounds for 3 wk. Upon the removal of these compounds, cells were
induced to epithelial differentiation on two-dimensional collagen substratum for 2;3 wk. The differentiated progeny, called mammosphere-derived
epithelial cells (MDECs), were used for ChIP-seq analysis. (B) Flowchart showing step-wide identifications of chromosomal regions associated with ESR1-
mediated repression. Omics data, including ChIP-seq for differential RNA polymerase II (Pol II) binding sites and MeDIP-chip for DNA methylation
profiling, were acquired for identifying the epigenetically repressed regions in the human genome. ChIP-chip and expression microarray data collected
from published information were coupled with omics data to identify the ESR1-mediated repressive regions. (C ) Genome-wide distribution of Pol II
binding sites in the human genome. After 3 wk of E2 or DMSO pre-exposure, MDECs were subjected to ChIP-seq with Pol II antibody. The binding
locations of Pol II were categorized into three groups, intragenic area, regions closed to transcription start sites (TSS), and intergenic region. Gene
definitions were taken from the UCSCGenome Browser’s RefGene table (Pruitt et al. 2007; Karolchik et al. 2008). For genes withmore than one isoform, all
TSSs were considered, but intragenic region measurements were taken from the longest isoform of the gene (less TSS regions). (D) Distribution of
differential expressed genes regulated by E2 in MDECs. Cutoffs for Pol II activity were determined by examining levels of enrichment within known
housekeeping genes and choosing the lower fifth percentile (Eisenberg and Levanon 2003). Similarly, cutoffs for lack of binding activity were established
by studying enrichment values from gene desert regions. Comparing the E2-pretreated and control mammosphere populations, we found 1106 activated
(left) and 683 repressed (right) genes upon E2 treatment. (E ) Genome-wide sound-track of differential gene expression in response to E2 treatment in
human normal and malignant cells. ChIP-seq with Pol II antibody was conducted on E2-treated MDECs (red track) and MCF-7 cells (blue track).
Estrogen-mediated repression by DNA looping
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rat in Supplemental Table S3), we extended the above study to a rat
model with prepubertal BPA exposure (250 mg/kg BW/day; Fig. 4D,
top). Expression profiling of mammary glands collected from pre-
exposed 50-d-old rats (n = 4) revealed concurrent repression in 10
genes homologous to those of the 16p11.2 loci (bottom). More-
over, down-regulation was apparent for 75 rat genes located in the
other 10 aforementioned regions (Supplemental Fig. S5). Taken
together, these findings suggest that (1) this conserved cluster is
susceptible to estrogen-mediated repression in bothhuman and rat
mammary epithelial cells, and (2) continuous exposure to estro-
genic ligands may lead to permanent silencing of the 16p11.2 loci.
Concurrent silencing of the 16p11.2 gene cluster is associated
with H3K27me3 and DNA hypermethylation in breast
cancer cells
Based on the pharmacologic study described in Figure 4B, we
proposed that repressive chromatin marks may be recruited to the
16p11.2 loci in cancer cells. One such mark is the polycomb-
modified H3K27me3, which is frequently present in promoter
regions of silent genes (Cao et al. 2002; Cao and Zhang 2004). ChIP-
qPCRwas used to determine enrichment levels of H3K27me3 in the
59-end regions (3 to 1 kb from each TSS) of the 14 genes inMDECs
and MCF-7 cells (Fig. 5A). In E2-stimulated MDECs, a low level of
enrichment was observed in these gene promoters for a 24-h period.
Interestingly, H3K27me3 enrichment was
greatly enhanced (two- to fourfold) in
unstimulated MDECs with prior exposure
to estrogen during the mammosphere
stage. This polycomb-mediated repression
was more dramatic when MCF-7 breast
cancer cells were stimulated with E2; sig-
nificant increases (eight- to 10-fold) in
H3K27me3 recruitment were found in at
least 12 of the 14 genes analyzed. This
enrichment was not present in two other
repressed genes, SPN andMVP, suggesting
that other repressive histone marks may
be involved in regulating these two gene
repressions. Taken together, the results
indicate that (1) prolonged exposure of
breast epithelial cells to estrogen may es-
tablish a ‘‘semirepressive’’ chromatin state
in the 16p11.2 area, and (2) upon activa-
tion of estrogen signaling, this hetero-
chromatic environment further promotes
incremental repression of the loci in breast
cancer cells.
To confirm the global methylation
profiling of the gene cluster, we con-
ducted bisulfite sequencing in 18 of 20
CpG islands located within this region in
breast normal and cancer cells (Fig. 5B; see also Supplemental
Fig. S6 for the sequenced regions). High to moderate (90%–30%)
levels of DNA methylation were found in 12 (67%) of the 18 CpG
islands in MCF-7 cells relative to MDECs (Fig. 5B). Among these,
hypermethylation was observed in eight of nine promoter CpG
islands; however, existing methylation of the ASPHD1, KCTD13,
and TMEM219 CpG islands (n = 4) was already present in MDECs.
The remaining six CpG islands (numbers 4, 5, 9, 10, 11, and 19)
exhibited low (<30%) or no methylation in this epigenetically re-
pressed cluster in cancer cells. Furthermore, five other genes, SPN,
QPRT, ZG16, SEZ6L2, and DOC2A do not have CpG islands lo-
calized near their 59-end promoter regions; as shown in Figure 4, we
found that the expression of these non-CpG island containing
genes was similarly repressed through estrogen signaling in breast
cancer cells. While hypermethylation of local CpG islands may not
be a dominant epigenetic feature in this estrogen-mediated repres-
sion, our data suggest that both DNA-methylated and neighboring
unmethylated genes could be coordinately regulated by a common
mechanism in a large chromosomal region.
Concurrent silencing of the 16p11.2 gene cluster is mediated
through ESR1-modulated DNA looping
Based on the above observation, we speculated that repression of
this 14-gene cluster may be remotely controlled by two functional
ESR1 binding sites, termed ESR1-1 and ESR1-2, located 13-kb apart
near the ZG16 locus (see the ChIP-qPCR results in Supplemental
Fig. S7). Long-range interactions, throughDNA looping, have been
shown to regulate gene transcription (West and Fraser 2005;
Kleinjan and Lettice 2008). To investigate whether such spatial
networking is operating on the 16p11.2 cluster, we conducted
chromosome conformation capture (3C)-qPCR assay (Hagege et al.
2007), a technique for detecting cross-linking frequencies between
gene promoters and distant binding sites. In E2-stimulated
MDECs, the frequency of DNA looping between these promoters
Table 1. Total sequence reads of RNA polymerase II binding by
ChIP-seq
Sample Treatment
No. of
reads
No. of mapped
reads Percent
MDEC Control 5,977,536 4,063,019 68
E2 pre-exposed 5,646,289 3,218,856 57
MCF-7 Control 4,373,268 3,521,976 81
E2 stimulated (4 h) 2,824,391 2,156,106 76
Figure 2. Genome-wide mapping of DNA methylation in MCF-7 breast cancer cells. MCF-7 cells
were stimulated with E2 for 4 h and then subjected to MeDIP-chip. Combined with Pol II ChIP-seq data
of MDECs and MCF-7 cells, 11 hypermethylated zones, as indicated by the blue open rectangles, are
potential regions susceptible to estrogen-mediated epigenetic silencing.
Hsu et al.
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and ESR1-1 was gradually increased (4.3- to 9.6-fold) within 24 h
(Fig. 6B, brown labels). DNA loop formation was not detected in
control regions distal from the transcription start sites (#11 and
#12) and in the 39-end (#14 and #15) or intragenic (#27 and #28)
regions of selected genes. When these cells were pretreated with
the ESR1 inhibitor ICI182780, we observed reduced frequencies
(1.2- to 2.6-fold) of DNA loop formation in E2-stimulated MDECs,
suggesting a direct role of ESR1-1 in mediating this loop formation
(Fig. 6B, pumpkin labels). However, this ESR1-mediated loop for-
mationwas not apparent in theMCF-7 cancer linewhen these cells
were stimulated with E2 (Fig. 6C).
Interestingly, loop interactions were already present between
ESR1-2 and the majority of promoters (except #2 and #15) in
unstimulated MDECs (Fig. 7B, left), and by 24 h after the E2
treatment, these existing loops disappeared. This DNA de-looping
process was abrogated in MDECs pretreated with ICI182780.
Again, low frequencies of loop formation were observed in the
16p11.2 region in MCF-7 cells, and no DNA movement was ob-
served in these cells treated with E2 (Fig. 7B, right).
These 3C-qPCR data, therefore, sug-
gest that ESR1-regulated transcriptional
repression operates through DNA loop-
ing in a three-dimensional sphere within
the nucleus. This regulatory mechanism
is flexible in normal cells, allowing for
free chromosome movement in response
to estrogen signaling. Looping plasticity
is significantly reduced in breast cancer
cells, and the establishment of rigid loop
structures may coordinately impose long-
term repression of multiple loci in a large
chromosomal region.
Discussion
Frigola et al. (2006) were first to elegantly
describe LRES in colorectal cancer and
systematically explore mechanisms lead-
ing to this coordinate epigenetic re-
pression in large chromosomal regions. A
favored model for LRES is the ‘‘silencing
and seeding’’ theory (Bock et al. 2006;
Feltus et al. 2006). In a contiguous region,
CpG island-related genes are actively
transcribed in normal cells, and this active
transcription can be a key determinant in
protectingCpG islands fromdenovoDNA
methylation (Bock et al. 2006; Feltus et al.
2006; Clark 2007). Loss of transcription
activity and thus disruption of the protec-
tive mechanism may allow DNA methyla-
tion to gradually spread from pre-existing
methylated sites to neighboring CpG is-
land shores (Irizarry et al. 2009). These
peripheral regions (up to 2 kb) located
close to CpG island cores can be frequently
methylated in cancer and are associated
with the silencing of corresponding genes
(Irizarry et al. 2009). In a series of events,
increased methylation of CpG sites may
serve as seeds to further propagate the
repressive information to other nearby
regions. Furthermore, de novo DNA methylation may act in con-
cert with histone lysine methylation to promote permanent re-
pression in targeted regions (Lorincz et al. 2002, 2004; Clark 2007).
In the case of CpG island-less genes also located in the region,
histone methylation may occur independently of DNA methyla-
tion to repress these loci (Lorincz et al. 2004; Frigola et al. 2006).
In contrast to this previous concept of epigenetic repression,
our present finding of estrogen-mediated LRES offers a different
perspective. Unlike the common notion that active transcription
of a locus may shield the corresponding CpG island from meth-
ylation-mediated repression, the contiguous loci identified in 11
chromosomal regions actually have the propensity to undergo
transcriptional silencing in normal cells. Specifically, the expres-
sion of the 14-gene cluster on 16p11.2 is concurrently down-
regulated in normal breast epithelial cells stimulated with E2 or
other estrogen-like ligands. The repression is transiently regulated
by the binding of ESR1 to target sites in the nucleus (Supplemental
Fig. S8). After the E2 stimulation, ESR1 gradually returns to the
cytoplasm (Supplemental Fig. S8A), and the transcription of this
Figure 3. Concurrent silencing of a gene cluster on chromosome 16p11.2. (A) Representative example
of a repressive gene cluster (black, n = 14) on chromosome 16p11.2 identified through integrative
mapping. Within this gene cluster, HIRIP3 (blue) was found to be positively regulated by ESR1. The ex-
pression of this gene was used as a positive control for the study. (B) In silico expression analysis of the
16p11.2 cluster in 48 breast cancer cell lines. Microarray expression data (Neve et al. 2006) of nine of the
14 geneswere available for the construction of a heatmap as shown. Statistical analysis used to distinguish
ESR1-positive from ESR1-negative breast cancer cell lines was calculated by Wilcoxon rank sum test.
Estrogen-mediated repression by DNA looping
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gene cluster is restored to the basal level. However, this transient
control is deregulated in normal epithelial cells chronically
exposed to estrogen or estrogen-like chemicals and in ESR1-
dependent breast cancer cells (Stenoien et al. 2001; Hsu et al.
2009). Persistent retention of nuclear ESR1 (Supplemental Fig. S8B)
is frequently observed in these neoplastic cells, leading to long-
term repression of the 16p11.2 gene locus. Based on the finding
presented in Figure 5A, we further suggest that this repression is
initiated by the recruitment of the H3K27me3 repressive chro-
matin mark to target loci. The programmed repression then sets
the stage for progressive accumulation of DNA methylation in
corresponding CpG islands during tumorigenesis.
Whereas the aforementioned ‘‘seeding and spreading’’ theory
may be used to explain progressive accumulation of DNA meth-
ylation in individual loci, this two-dimensional linear model is
inadequate to support our observation of estrogen-mediated LRES
in large chromosomal regions. Our 3C-qPCR data supports an al-
ternative mechanism in the context of three-dimensional chro-
mosome movement. Within the 16p11.2 cluster, existing DNA
loops form a sunflower-shaped configuration that coordinately
Figure 4. ESR1-mediated concurrent silencing of a 14-gene cluster on chromosome 16p11.2. (A) Progressive repression of the 14-gene unit in
mammosphere-derived epithelial cells treated with 17b-estradiol (E2, 70 nM) or diethylstilbestrol (DES, 70 nM). Total RNA was isolated and subject to
quantitative RT-PCR analysis from three independent sets of MDEC samples. Expression data are summarized in heat maps (see also detailed results in
Supplemental Fig. S2). (B) ESR1-mediated epigenetic repression of the gene cluster in MCF-7 cells. Six hours before E2 stimulation, cells were pretreated
with 5-aza-29-deoxycytidine (DAC, 1mM), trichostatin A (TSA, 1mM), and/or ESR1 antagonist ICI182780 (ICI, 1mM). Total RNAwas subjected to RT-qPCR
analysis, and expression data are summarized in heatmaps (see also detailed results in Supplemental Fig. S3). (C ) Coherent repression of the 16p11.2 gene
cluster in differentiated cells pre-exposed to endocrine disruptors. Progenitors were exposed to E2 (70 nM), diethylstilbestrol (DES, 70 nM), daidzein (10
mM), 1,3,5-tris(4-hydroxyphenyl)- 4-propyl-1H-pyrazole (PPT, 0.1 nM), 4-nonylphenol (NP, 1 mM), N-butyl-benzyl phthalate (BBP, 10 mM), di(2-eth-
ylhexyl)-phthalate (DEHP, 10 mM), 4,49-dichloro-biphnyl (PCB, 0.1 nM), and bisphenol A (BPA, 4 nM) for 3 wk. After the pre-exposure, the differentiated
cells in the absence of estrogenic exposure were subjected to RT-qPCR analysis. Data was calculated from three independent sets of MDEC samples and
presented in heat maps (see also detailed results in Supplemental Fig. S4). (D) Concurrent silencing of 16p11.2 homologs (n = 10) in a rat model pre-
exposed to bisphenol A (BPA). After birth, rats were exposed to sesame oil (Ctrl) or BPA (Treated; 250 mg/kg BW) during the prepubertal period (;21 d).
Then, total RNA of mammary gland obtained from 50-d-old animals prepubertally exposed to BPA were collected for expression analysis. Results of four
independent sets of rat samples are shown in heat maps (see also detailed results in Supplemental Fig. S5)
Hsu et al.
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Figure 5. (Legend on next page)
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brings these promoters to a common region within ESR1-2 for
basal transcription (see the proposed model in Fig. 7C). Upon
signaling activation, ESR1 binding to ESR1-2 may ‘‘dissolve’’ this
configuration, subsequently releasing active transcription com-
plexes (e.g., p160 coactivator complex andmediators) (Perrissi and
Rosenfeld 2005) from the loop structure. A second wave of DNA
loops forms another sunflower-shaped structure, shifting the focal
interaction with ESR1-1. This newly formed center serves as
a docking site for recruiting repressor complexes (e.g., NCoR and
SMART) (Perrissi and Rosenfeld 2005) for gene silencing. These
long-range interactions are transient, depending upon the timing
of signaling activation in epithelial cells. However, chronic expo-
sure of normal cells to estrogen or constant growth stimulation of
neoplastic cells results in loss of looping dynamics. In the case of
the 16p11.2 cluster, persistent signaling stimulation may drive
target genes into epigenetic silencing. The permanent loop struc-
ture may represent a previously undescribed epigenetic phenom-
enon used to establish permanent silencing of genes in breast
cancer cells. Within this 14-gene cluster, DNA hypermethylation
was only found in 12 of 18 CpG islands examined in breast cancer
cells. One plausible explanation is that loop structure may serve as
a dominant feature for heterochromatinization of the entire gene
cluster, while de novo DNA methylation is a stochastic process,
operating at the local level to reinforce epigenetic repression of
individual loci.
Our present findings challenge the prevailing concept of ‘‘one
repressor unit for one silenced gene.’’ In a nuclear microenviron-
ment, ligand-mediated actions may operate in different tran-
scription units. In our case, upon signaling activation, at least two
cis-regulatory elements collaborativelymodulate intrachromosomal
interactions, resulting in deactivation of a 14-gene unit. Multiple
genes located on different chromosomes can also be regulated as an
interchromosomal unit (Go¨ndo¨r andOhlsson 2009; Hu et al. 2009).
Further identification of their intra- and interchromosomal co-
partners may provide insight into complex transcriptional regula-
tion within a cell in response to estrogen stimulation. Integrative
epigenomics, as demonstrated in this study, therefore represents
a powerful research tool to investigate this type of epigenetic phe-
nomenon in cancer cells.
Methods
Tissue samples and cell culture
Breast samples were collected by the tissue procurement service in
accordance with the protocols approved by the Institutional Re-
view Board of The Ohio State University. For isolation of breast
progenitors, normal tissue sections were obtained from individuals
undergoing reduction mammoplasties mainly due to macromastia.
These tissues were dissociatedmechanically and enzymatically, and
single cells were isolated and grown into mammospheres (2000–
10,000 cells per mammosphere) in ultra-low attachment plates
(Corning) in serum-free mammary epithelial growth medium
(Cambrex) as described (Dontu et al. 2003). These mammospheres
could be repopulated in the suspension culture up to six cell pas-
sages (Cheng et al. 2008). Mammospheres were then exposed to
different estrogen-like chemicals with optimal concentration or
DMSO (control) in phenol red-free medium for 3 wk (medium
changed twice weekly). After the exposure, mammosphere-con-
taining progenitors were placed on a collagen substratum (BD Bio-
sciences) in phenol red-free medium for 2;3 wk, with removal of
chemicals. Under this culture condition, progenitors were differ-
entiated into breast epithelial cells as described previously (Cheng
et al. 2008; Hsu et al. 2009). The MCF-7 breast cancer cell line was
obtained from the American Type Culture Collection for in vitro
studies.
Chromatin immunoprecipitation (ChIP)
Immunoprecipitated DNA from each of treated MDECs or MCF-7
cells was prepared according to the ChIP protocol published by Lee
et al. (2006). Briefly, treated cells were fixed with 1% formaldehyde
at room temperature for 10 min. The resultant DNA–protein
complexes were sheared with a Bioruptor (Diagenode) to an aver-
age of 450 bp as verified on a 1.5% agarose gel, followed by im-
munoprecipitation using the Dynabeads Protein G (100.04D;
Invitrogen) coated with antibodies specific for the POLR2A sub-
unit of RNA polymerase II (Santa Cruz Biotechnology, Inc., sc-
899C), ESR1 (Santa Cruz Biotechnology, Inc.), and trimethylation
of histone H3 lysine 27 (H3K27me3; Diagenode). Pull-down DNA
was subjected to sequencing or quantitative PCR.
ChIP coupled with massively parallel sequencing (ChIP-seq)
and data analysis
MCF-7 cells were stimulatedwith E2 orDMSO for 4 hDMSO- or E2-
pre-exposed MDECs and treated MCF-7 cells were subjected to
ChIP assay by using anti-RNA polymerase II antibody. Immuno-
precipitated DNA was then applied to massively parallel sequenc-
ing. The whole-genome sequence analysis was performed by the
BC Cancer Agency Genome Sciences Center (BCGSC). Briefly,
ChIPDNA (>5 ng) per sample sonicated to the range of from 200 to
600 bp (quantified by the NanoDrop 3300 Fluorospectrometer
following the PicoGreen protocol) was submitted to BCGSC for
Illumina 1G analysis (two lanes per sample). The library prepara-
tion and Illumina Pipeline analysis for ChIP-seq samples were
routine and well described in a recent paper from the BCGSC
(Robertson et al. 2007). After extracting raw data from the Se-
quencer, the number of reads sequenced within nonoverlapping
kilobase-sized bins was modeled using a normal approximation to
a Poisson distribution with mu equal to the mean number of reads
per bin (excluding unsampled bins). Modeling was performed on
a per-chromosome basis. Enrichment scores were calculated for
each bin as 10p(x # X), giving a score with a range from zero (no
probability of binding) to 10 (100% probability of binding).
Figure 5. Epigenetic changes in the 16p11.2 region. (A) Distribution patterns of the repressive H3K27me3 mark in the 16p11.2 region. The diagram
indicates the regions surveyed by ChIP-qPCR. The locations of interrogating regions (3 to +1 kb of TSS) were labeled in red. DNA samples from E2-
stimulatedMDECs andMCF-7 cells and E2-pre-exposedMDECs were immunoprecipitated with anti-H3K27me3 antibody. Immunoprecipitated DNAwas
subjected to quantitative PCR to measure enrichment levels of H3K27me3. Mean 6SD (n = 3). (B) De novo DNA methylation analysis of CpG islands
located on the 16p11.2 region. The diagram indicated the genomic locations of 20 CpG islands on the 16p11.2 region. The analyzed CpG islands (n = 9;
nos. 5, 6, 7, 13, 14, 15, 16, 17, 18) located at the promoter and first exon regions of genes were labeled in red; other nonpromoter CpG islands (n = 9; nos.
2, 3, 4, 8, 9, 10, 11, 12, 19) were labeled in green. Two unanalyzed CpG islands were labeled in black. DNAmethylation of 18 of 20 CpG islands located on
the 16p11.2 region was surveyed by bisulfite sequencing. Primers flanking the cores of these CpG islands were designed for PCR amplification of bisulfite-
treated DNAs from normal (MDEC) and cancer (MCF-7) cells. Ten clones per CpG island were selected for sequencing. (Black dot) methylated CpG
dinucleotide; (white dot) unmethylated CpG nucleotide. Methylation percentage is calculated from the number of black dots to total dots in each sample.
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Figure 6. Generation of ESR1-1-mediated DNA loops in the 16p11.2 gene cluster. (A) Diagram of a genomic region surveyed by chromatin confor-
mation capture (3C)-qPCR assays. Forty reactions (number in violet) of 3C-qPCR were performed in BbvCI-digested DNA samples. Areas (red) selected for
3C-qPCR were frequently localized at the 59-ends of genes. Inter- and intragenic regions (green) were also selected as negative controls for the assay.
(B) Formation of DNA loops at ESR1-1 upon E2 stimulation in normal cells. In the presence of E2, MDECs were treated without (E2) or with (E2+ICI) the
ESR1 antagonist, ICI182780 (ICI, 1 mM) for two time-periods (0.5 and 24 h). BbvCI-digested DNA fragments were subjected to 3C-qPCR. Data are shown
in relative cross-linking frequencies comparedwith that ofGAPDH as an internal control. Mean6SD (n = 3). (C ) Formation of DNA loops at ESR1-1 in breast
cancer cells. BbvCI-digested DNA fragments from E2-stimulated MCF-7 cells (0.5 and 24 h) were subjected to 3C-qPCR. Data are shown in relative cross-
linking frequencies compared with that of GAPDH as an internal control. Mean 6SD (n = 3).
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Figure 7. Generation of ESR1-2-mediated DNA loops in the 16p11.2 gene cluster. (A) Diagram of a genomic region interrogated by 3C-qPCR. Twenty
reactions (number in blue) of 3C-qPCRwere conducted in BamHI-digestedDNA samples. Areas (red) selected for 3C-qPCRwere frequently localized at the
59-ends of genes. Inter- and intragenic regions (green) were also selected as negative controls for the assay. (B) Diminution of DNA loop formation by E2
treatment. After E2 stimulation, 3C-qPCR was conducted by using BamHI-treated DNA samples of MDECs (left) andMCF-7 cells (right). Data are shown in
relative cross-linking frequencies compared with that of GAPDH. Mean6SD (n = 3). (C ) Proposed DNA loop model of the 16p11.2 gene cluster in normal
and cancer cells. In normal breast epithelial cells, estrogen stimulation induces the formation of newDNA loops at ESR1-1 and diminishes the existing DNA
loops at ESR1-2. In contrast, this free DNAmovement is not present inMCF-7 breast cancer cells treated with estrogen (see detailed description in the text).
(Red dot) ESR1-1 binding site; (green dot) ESR1-2 binding site.
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Methylated DNA immunoprecipitation microarray
(MeDIP-chip) and data analysis
Methylated DNA from MCF7 cells was prepared according to the
protocol published by Weber et al. (2005). Briefly, high-quality ge-
nomic DNAwas sheared to 300 bp (fragment size ranging from 200
to 600 bp) using Bioruptor. Fragmented DNAwas heat denatured to
produce single-stranded DNA to enhance the immunoselection
step. Antibodies against 5-methyl cytidine (MAb-335MEC-500;
Monoclonal Methyl DNA IP-grade; 1 mg/mL; Diagenode) were
complexed to the magnetic beads (pan-mouse IgG Dynal Beads,
Invitrogen). The immunoprecipitated methylated DNA fragments
were processed by the NimbleGen Methylation Microarray Service
(NimbleGen Systems, Inc.). Methylation analysis was performed on
the NimbleGen Two-Array HG18 Promoter Set. This two-chip array
designs relies on RefSeq to span the promoter regions of all well-
characterized genes currently available for the human genome with
total coverage of 54 Mb with 385 K probes per array. Every sample
was hybridized twice, with MeDIP sample labeled with cyanine-5
dye and sonicated genomic DNA labeled with cyanine-3 dye in one
of the microarray analyses and the second being a dye-swap anal-
ysis. The microarray-scanned images from the HG18 Promoter Set
were captured as signal intensity, which were converted to scaled
log2-ratio data. The intensity ratio of theMeDIP sample to totalDNA
was plotted genomic position to identify regions of enrichment.
P-value files were generated from the scaled log2-ratio data to test for
positive enrichment of DNA methylation for each probe against all
probes on the array. Peak files identifying regions of DNA methyl-
ation were generated from the P-value files and the enriched peaks
were then mapped to the transcription start site of each gene.
Bisphenol A (BPA) exposure in a rat model
and microarray analysis
Animal care and use were conducted according to established
guidelines approved by the Institutional Animal Care and Use
Committee at the University of Alabama at Birmingham. All ani-
mals were housed in a temperature controlled facility with a 12 h
light/dark cycle. Female Sprague Dawley CD rats (Charles River)
were bred and observed for the presence of sperm. Once sperm
positive, noted as gestational day 0, females were separated, housed
in polypropylene cages with glass water bottles (both poly-
carbonate/BPA free), and fed the phytoestrogen-free AIN-93G pel-
leted diet. At birth, offspring were sexed and litters were culled to 10
offspring per lactating dam. Beginning on postnatal day two and
continuing through postnatal day 20, the lactating dam of each
litter was intragastrically gavagedwith sesame oil for controls or 250
mg of Bisphenol A/kg BW/day. The offspringwereweaned at 21 d. At
day 50, the fourth abdominalmammary glandswere dissected from
females in the estrous phase of the estrous cycle at the same time
each day using ketamine/xylazine anesthesia for live collection. The
samples were flash frozen in liquid nitrogen, stored at 80°C, and
subsequently shipped under dry ice.
Total RNA (200ng) from themammary gland of each 50-d-old
rat with prepubertal exposure of BPA or sesame oil was hybridized
onto the rat Agilent platformof 60-mer oligo-microarrays (43 44 K).
The data from each microarray was adjusted for background noise
using the normexp procedure, and normalized by fitting the lowess
curve to the of log-ratios of Cy5 to Cy3 channel and the average
log-intensities of the two as implemented in the limma package
(Supplemental Table S4).
RT-qPCR and ChIP-qPCR
Total RNA (2 mg) was reversely transcribed to cDNA with oligo-dT
(SuperScript III; Invitrogen). Quantitative RT-PCR was performed
by using SYBR Green dye chemistry (Applied Biosystems) on
a 7500 real-time PCR System apparatus (Applied Biosystems). Gene
expression was calculated by absolute quantitation of standard
curves of cloned PCR products. The curves were amplified from
universal human reference RNA (Stratagene) with primers for each
gene. Results of gene expression are presented as the relative ex-
pression level of the given gene to ACTB reference control for each
sample. Immunoprecipitated DNA by anti-H3K27me3 or anti-
ESR1 antibody was subjected to quantitative PCR analysis. PCR
primers targeting H3K27me3 or two ESR1 binding sites were used
to amplify DNA samples using the SYBR Green-based detection
method. Quantitative values measured by a standard curve (50 to
0.08 ng, fivefold dilution, R2 > 0.99) of input DNA amplified with
the same primer set. Results are presented as themean of triplicates
with standard derivation. Details of primer sequence for quantifi-
cations are provided in Supplemental Table S5.
Inhibitor treatments
MCF-7 cells were treated with 1 mM 5-aza-29-deoxycytidine (DAC)
for 5 d in MEMmedium containing 10% FBS and 6 ng/mL insulin.
During the final 72 h of the DAC treatment, cells were hormone
deprived by culturing in phenol red-free MEM supplemented with
4% charcoal-dextran-treated FBS. During the final 24 h of hor-
mone deprivation, cells were treated with 1 mM trichostatin A
(TSA) and/or an ESR1 antagonist, ICI182780 (1 mM), or DMSO
followed by treatment with DMSO (control) or 70 nM E2 for 6 h.
Total RNA was collected for RT-qPCR analysis. For 3C-qPCR assay,
MDECs without E2 pre-exposure were pretreated with ICI182780
(1 mM) for 24 h prior to E2 stimulation.
Bisulfite sequencing
DNA (0.5 mg per sample), isolated fromMDECs or MCF-7 cells, was
treated with sodium bisulfite using the EZ DNA Methylation kit
(ZYMO Research). Primers flanking the cores of 18 CpG islands
in the chr16p11.2 region were designed for PCR amplification of
bisulfite-treated DNAs. Details of primer sequence for quantifica-
tions are provided in Supplemental Table S5. PCR products were
cloned into the TOPO TA cloning kit (Invitrogen). Ten randomly
picked clones per CpG island were sequenced using the ABI 3730
DNA analyzer (Applied Biosystems) and then analyzed using the BiQ
Analyzer.
Chromosome conformation capture (3C)-qPCR
Chromosome conformation capture assay combined with quan-
titative PCR analysis (3C-qPCR) was performed as previously de-
scribed (Hagege et al. 2007). Briefly, E2-pre-exposed MDECs were
fixedwith 1% formaldehyde. Chromatinwas digested using BbvCI
(for ESR1-1) and BamHI (for ESR1-2), and then ligated by T4 DNA
ligase in diluted condition. Ligated DNA was then de-cross-linked
(overnight at 65°C) and purified by classical phenol extraction
procedures. Real-time PCR was performed on a 7500 Real-Time
PCR System apparatus (Applied Biosystems) using the TaqMan
technology (QuantiTect Probe PCR Master Mix, Qiagen). We used
a 59FAM-39BHQ1 oligonucleotidic probe (IDT). Details of primer
sequence for quantifications are provided in Supplemental Table
S5. To rule out the possibility of false-negative looping occurrence
caused by unsuccessful 3C assay, we pooled three human bacterial
artificial clones (BAC), mapping the interested regions as the pos-
itive control to the 3C assay. BACs were also used to examine the
primer efficiency. Ct values obtained for each chimerical ligation
fragment were processed using parameters of a standard curve
(slope and intercept) fromBAC to obtain quantification values that
were normalized to aGAPDH loading control. Results are presented
as the mean of triplicates with standard derivation.
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Statistical analysis
All data were presented as the mean 6SD of n independent mea-
surements. Statistical comparisons between two groups weremade
by Student’s t-test using SigmaPlot 11. For samples with equal
variance, the paired Student’s t-test was used. For samples with
unequal variance, the Mann-Whitney rank sum test was used.
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